Day Zero Diagnostics
Emily MacLeod has worked for three companies since 2018. Emily began as a Social Media Coordinator and Production Assistant for Phase Genomics in 2018. In 2020, they joined the Greenberg Lab at the University of Washington Microbiology as an Undergraduate Student Researcher. Currently, they are a Senior Research Associate I at Day Zero Diagnostics, Inc, a role they have held since 2021. Prior to this role, they were a Research Associate II and Research Associate I at Day Zero Diagnostics, Inc.
Emily MacLeod graduated from the University of Washington in 2021 with a Bachelor of Science in Molecular, Cellular, and Developmental Biology. Emily began their studies at the University of Washington in 2017.
Day Zero Diagnostics
The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.